The MprF homolog LysX synthesizes lysyl-diacylglycerol contributing to antibiotic resistance and virulence.
Gill. Cameron P CP; Phan. Christopher C; Platt. Vivien V; Worrell. Danielle D; Andl. Thomas T; Roy. Hervé H
Key Findings
- LysX enzyme creates lysyl‑diacylglycerol (Lys‑DAG) in several actinobacteria
- Lys‑DAG strongly protects bacteria from LL‑37, polymyxin B, gentamycin and apramycin
- Removing lysX increases membrane permeability, reduces antibiotic resistance and lowers virulence in infection models
Practical Outcomes
- For DIY health enthusiasts there is no direct way to use this information to improve personal health or performance. It mainly warns that bacteria can develop strong resistance to LL‑37, so any future attempts to use LL‑37 as a supplement or therapy need to consider possible bacterial counter‑measures.
Summary
The study shows that a bacterial protein called LysX adds a lysine molecule to a lipid (Lys‑DAG), which makes the bacteria much more resistant to the human antimicrobial peptide LL‑37 and other antibiotics, and also makes them more virulent. Deleting the LysX gene makes the bacteria more vulnerable and less able to cause infection.
Abstract
Lysyl-diacylglycerol (Lys-DAG) was identified three decades ago in <i>Mycobacterium phlei</i>, but the biosynthetic pathway and function of this aminoacylated lipid have since remained uncharacterized. Combining genetic methods, mass spectrometry, and biochemical approaches, we show that the multiple peptide resistance factor (MprF) homolog LysX from <i>Corynebacterium pseudotuberculosis</i> and two mycobacterial species is responsible for Lys-DAG synthesis. LysX is conserved in most Actinobacteria and was previously implicated in the synthesis of another modified lipid, lysyl-phosphatidylglycerol (Lys-PG), in <i>Mycobacterium tuberculosis</i>. Although we detected low levels of Lys-PG in the membrane of <i>C. pseudotuberculosis</i>, our data suggest that Lys-PG is not directly synthesized by LysX and may require an additional downstream pathway, which is as yet undefined. Our results show that LysX in <i>C. pseudotuberculosis</i> is a major factor of resistance against a variety of positively charged antibacterial agents, including cationic antimicrobial peptides (e.g., human peptide LL-37 and polymyxin B) and aminoglycosides (e.g., gentamycin and apramycin). Deletion of <i>lysX</i> caused an increase in cellular membrane permeability without dissipation of the membrane potential, suggesting that loss of the protein does not result in mechanical damage to the cell membrane. Furthermore, <i>lysX</i>-deficient cells exhibited an attenuated virulence phenotype in a <i>Galleria mellonella</i> infection model, supporting a role for LysX during infection. Altogether, Lys-DAG represents a novel molecular determinant for antimicrobial resistance and virulence that may be widespread in Actinobacteria and points to a richer landscape than previously realized of lipid components contributing to overall membrane physiology in this important bacterial phylum. IMPORTANCE In the past two decades, tRNA-dependent modification of membrane phosphatidylglycerol has been implicated in altering the biochemical properties of the cell surface, thereby enhancing the antimicrobial resistance and virulence of various bacterial pathogens. Here, we show that in several Actinobacteria, the multifunctional protein LysX attaches lysine to diacylglycerol instead of phosphatidylglycerol. We found that lysyl-diacylglycerol (Lys-DAG) confers high levels of resistance against various cationic antimicrobial peptides and aminoglycosides and also enhances virulence. Our data show that Lys-DAG is a lipid commonly found in important actinobacterial pathogens, including <i>Mycobacterium</i> and <i>Corynebacterium</i> species.
Study Information
pubmed
2023
2023-09-28T00:00:00.000Z
10.1128/spectrum.01429-23
1
95